AMPICILLIN AND SULBACTAM FOR INJECTION

The Defense Logistics Agency awarded a delivery order under the base contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of AMPICILLIN AND SULBACTAM FOR INJECTION, with a total contract value of $48.58. The award was issued on July 16, 2026, and the delivery is to be made FOB destination to Electric Boat Corporation in Groton, Connecticut, with the contractor responsible for all transportation costs. This transaction falls under FAR Part 12 as a commercial item acquisition, incorporating standard clauses including 52.212-1, 52.212-3, 52.212-4, and 52.212-5, with no alternates or additional fill-ins applied. The contractor is certified as a small business with additional socioeconomic status as a Small Disadvantaged Business and a Women-Owned Small Business, and the acquisition was competitively set aside for small businesses. Payment is governed by code SL4701, administered by the Defense Finance and Accounting Service, with invoicing required through the Wide Area Workflow system per DFARS 252.232-7003 and payable under Fast Pay Net 15 terms. The item is to be accepted at the destination upon government inspection, with no specific packaging, preservation, or marking standards referenced; however, tracking identifiers such as ship and voucher numbers are included for logistics coordination. The base contract has a ceiling of $20 million, though only this single line item was activated and priced. Contract administration is overseen by Lisa Quinn and other DLA personnel, with no designated COR/COTR named, implying the contracting officer assumes oversight responsibilities. All deliverables, payment, and compliance obligations are defined within the standard commercial items framework, with no special requirements, performance metrics, or technical specifications beyond the item description and delivery terms provided.